editorial comment

1
INTERNATIONAL PROSTATE SYMPTOM SCORE FOR OUTCOME OF TRANSURETHRAL PROSTATECTOMY 99 tatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Brit. J. Urol.. 76: 451, 1995. 5. Mebust, W. K., Roizo, R., Schroeder, F. and Villers, A,: Correla- tions between patholom, clinical symptoms and the course of the disease. In: Proceedings of the International Consultation on Benign Prostatic Hyperplasia, pp. 53-62, 1991. 6. Lepor. H. and Machi. G.: Comparison of AUA symptom index in unselected males and females between fifty-five and seventy- nine yrars of age. Urology. 42: 36, 1993. 7. Cockett. A. T. K., Aso. Y.. Denis. L., Murphy, G., Khoury. S., P., Harry, M. J., Carlton, G. E., Fitzpatrick, J., ler, H.. Gibbons. R.. Griffiths, K., Hald, T., Holtgrewe, L.. .Jardin. A,, McDonnell. J. D., Mebust, W., Roehrborn, C. G., Smith, P. and the Members of the Committees: Recommenda- tions of the International Consensus Committee concerning the International Prostate Symptom Score and quality of life assessment. 2. Diagnostic work-up of men presenting with lower urinary tract symptoms suggestive of bladder outlet ihstruction. In: Proceedings of the 3rd, International Consul- tation on RPH. pp. 625-635, 1996. 8. .Jakobsen. H.. Torp-Pedersen. S. and Juul, N.: Uroflow variables and voiding symptoms relative to age in males with normal prostates and benign prostatic hyperplasia. Neurourol. Urody- nnni., 14: 477, abstract 44, 1995. 9. McNcil. 13. .J,+ Kel1t.r. E. and Adelstein, S. J.: Primer on certain tslcments of medical decision making. New Engl. J. Med.. 293: 211. 1975. 10. Hanlvy, .I, A. and McNeil, B. .J.: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radi- olok~~ 143: 29, 1982. 11. Harry. M. J., Williford. W. O., Chang, Y., Machi, M., Jones, K. M.. Walkcd:orkery, E. and Lepor, H.: Benign prostatic hyperpla- sia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J. Urol., 154: 1770, 1995. 12. Mebust. W. K.. Holtgrewe, H. L., Cockett, A. T. K., Peters, P. C. and Writing Committee: Transurethral prostatectomy: imme- diate and postoperative complications. A cooperative study of 13 DarticiDatina institutions evaluating 3,885 patients. J. U;ol., 141: 243, 1989. 13. Barrv. M. J.. Cockett. A. T. K., Holtmewe, H. L., McConnell, <J. b.. Sihelnik. S. A. and Winfield, H. N.: Relationship of symptoms of prostatism of commonly used physiological and anatomical measures of the severity of benign prostatic hyper- plasia. J. Urol.. 150 351. 1993. 14. Abrams, P. H., Farrar, D. J., Turner-Wanvick, R. T., Whiteside, C. G. and Feneley. R. C. L.: The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J. Urol., 121: 640, 1979. 15. Neal, D. E.. Ramsden. P. D.. Sharples, L.. Smith, A,, Powell. P. H., Styles. R. A. and Webb, R. J.: Outcome of elective prostatectomy. Brit. Med. J.. 299. 762, 1989. 16. Emberton. M.. Black, N.. Blandy, J. P.. McPherson, K., Devlin. B. H., Neal. D. E.. Fordham. M., Harrison, M., McBrien, M. P. and Williams, R. E.: The effectiveness of prostatectomy in reducing symptoms and improving the quality of life in 5131 men. J. Urol., part 2, 153: 317A. abstract 356, 1995. 17. Keoghane, S., Cranston, D., Lawrence, K., Doll, H., Fellows, G. and Smith, J.: The Oxford laser prostate trial: a prospective randomised controlled trial of contact vaporisation of the pros- tate versus TURP. J. Urol., part 2,153 230A, abstract 5,1995. 18. Gill, H. S. and Kabalin, J. N.: Urodynamic evaluation of patients in a randomised study of TURP versus laser prostatectomy: preoperative and one-year followup. Neurourol. Urodynam., 12: 372, 1993. 19. Horninger, W., Janetschek, G., Pointner, J., Watson, G. and Bartsch, G.: Are TULIP, interstitial laser and contact laser superior to TURF’? J. Urol., part 2. 153: 413A, abstract 738, 1995. 20. Fowler, F. J., Jr., Wennberg, J. E., Timothy, R. P., Barry, M. J., Mulley, A. G., Jr. and Hanley, D.: Symptom status and quality of life following prostatectomy. J.A.M.A., 259 3018, 1988. EDITORIAL COMMENT The authors use preoperative AUA symptom scores, and other variables perhaps reflecting BPH severity, to predict postoperative decreases in symptom score. Preoperative symptom burden ap- peared to be the best predictor of symptom response. For example approximately 87% of men with a preoperative symptom score of at least 17 points improved substantially (at least 7 points) with pros- tatectomy, while only 29% with lower preoperative scores responded as dramatically. This prognostic stratification based on symptom severity appears much more powerful than for some other predictors of surgical outcome examined in the literature, such as the preoper- ative presence or seventy of urodynamic obstruction. Treatment guidelines have emphasized that surgical treatment (or any treat- ment for that matter) should be avoided for men with symptom scores of less than 8 points. Perhaps the threshold symptom level before prostatectomy is rec- ommended should be even greater, although by how much depends on whether it is worse to operate on a man who will not improve substantially or to deny operative treatment to a man who will indeed improve substantially. The worse the former outcome is than the latter, the greater the symptom threshold should be for recom- mending surgery. An interesting caveat to this analysis is to note that the 11 men with symptom scores of 8 or less had a group mean improvement quality of life score of approximately 2 points, while the 48 with severe symptoms had a group mean improvement of approx- imately 3 points, which is not much greater. While the small sample size argues against overinterpreting this finding, one wonders what the former group of men were responding to when they rated the postoperative quality of life better even with no symptom improve- ment. Michael J. Barty Medical Practices Evaluation Center Massachusetts General Hospital Boston. Massachusetts

Upload: hoanghuong

Post on 30-Dec-2016

216 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: EDITORIAL COMMENT

INTERNATIONAL PROSTATE SYMPTOM SCORE FOR OUTCOME OF TRANSURETHRAL PROSTATECTOMY 99

tatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Brit. J. Urol.. 76: 451, 1995.

5 . Mebust, W. K., Roizo, R., Schroeder, F. and Villers, A,: Correla- tions between patholom, clinical symptoms and the course of the disease. In: Proceedings of the International Consultation on Benign Prostatic Hyperplasia, pp. 53-62, 1991.

6. Lepor. H. and Machi. G.: Comparison of AUA symptom index in unselected males and females between fifty-five and seventy- nine yrars of age. Urology. 42: 36, 1993.

7. Cockett. A. T. K., Aso. Y.. Denis. L., Murphy, G., Khoury. S., P., Harry, M. J., Carlton, G. E., Fitzpatrick, J.,

ler, H.. Gibbons. R.. Griffiths, K., Hald, T., Holtgrewe, L.. .Jardin. A, , McDonnell. J. D., Mebust, W., Roehrborn, C. G., Smith, P. and the Members of the Committees: Recommenda- tions of the International Consensus Committee concerning the International Prostate Symptom Score and quality of life assessment. 2. Diagnostic work-up of men presenting with lower urinary tract symptoms suggestive of bladder outlet ihstruction. In: Proceedings of the 3rd, International Consul- tation on RPH. pp. 625-635, 1996.

8. .Jakobsen. H.. Torp-Pedersen. S. and Juul, N.: Uroflow variables and voiding symptoms relative to age in males with normal prostates and benign prostatic hyperplasia. Neurourol. Urody- nnni., 14: 477, abstract 44, 1995.

9. McNcil. 13. .J,+ Kel1t.r. E. and Adelstein, S. J.: Primer on certain tslcments of medical decision making. New Engl. J. Med.. 293: 211. 1975.

10. Hanlvy, . I , A. and McNeil, B. .J.: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radi- o l o k ~ ~ 143: 29, 1982.

1 1 . Harry. M. J., Williford. W. O., Chang, Y., Machi, M., Jones, K. M.. Walkcd:orkery, E. and Lepor, H.: Benign prostatic hyperpla- sia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J . Urol., 154: 1770, 1995.

12. Mebust. W. K.. Holtgrewe, H. L., Cockett, A. T. K., Peters, P. C. and Writing Committee: Transurethral prostatectomy: imme- diate and postoperative complications. A cooperative study of 13 DarticiDatina institutions evaluating 3,885 patients. J. U;ol., 141: 243, 1989.

13. Barrv. M. J.. Cockett. A. T. K., Holtmewe, H. L., McConnell, <J. b.. Sihelnik. S. A. and Winfield, H. N.: Relationship of symptoms of prostatism of commonly used physiological and anatomical measures of the severity of benign prostatic hyper- plasia. J. Urol.. 1 5 0 351. 1993.

14. Abrams, P. H., Farrar, D. J., Turner-Wanvick, R. T., Whiteside, C. G. and Feneley. R. C. L.: The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J. Urol., 121: 640, 1979.

15. Neal, D. E.. Ramsden. P. D.. Sharples, L.. Smith, A,, Powell. P. H., Styles. R. A. and Webb, R. J.: Outcome of elective prostatectomy. Brit. Med. J.. 299. 762, 1989.

16. Emberton. M.. Black, N.. Blandy, J . P.. McPherson, K., Devlin. B. H., Neal. D. E.. Fordham. M., Harrison, M., McBrien, M. P.

and Williams, R. E.: The effectiveness of prostatectomy in reducing symptoms and improving the quality of life in 5131 men. J. Urol., part 2, 153: 317A. abstract 356, 1995.

17. Keoghane, S., Cranston, D., Lawrence, K., Doll, H., Fellows, G . and Smith, J.: The Oxford laser prostate trial: a prospective randomised controlled trial of contact vaporisation of the pros- tate versus TURP. J. Urol., part 2 ,153 230A, abstract 5,1995.

18. Gill, H. S. and Kabalin, J. N.: Urodynamic evaluation of patients in a randomised study of TURP versus laser prostatectomy: preoperative and one-year followup. Neurourol. Urodynam., 12: 372, 1993.

19. Horninger, W., Janetschek, G., Pointner, J., Watson, G. and Bartsch, G.: Are TULIP, interstitial laser and contact laser superior to TURF’? J. Urol., part 2. 153: 413A, abstract 738, 1995.

20. Fowler, F. J., Jr., Wennberg, J. E., Timothy, R. P., Barry, M. J., Mulley, A. G., J r . and Hanley, D.: Symptom status and quality of life following prostatectomy. J.A.M.A., 2 5 9 3018, 1988.

EDITORIAL COMMENT

The authors use preoperative AUA symptom scores, and other variables perhaps reflecting BPH severity, to predict postoperative decreases in symptom score. Preoperative symptom burden ap- peared to be the best predictor o f symptom response. For example approximately 87% of men with a preoperative symptom score of at least 17 points improved substantially (at least 7 points) with pros- tatectomy, while only 29% with lower preoperative scores responded as dramatically. This prognostic stratification based on symptom severity appears much more powerful than for some other predictors of surgical outcome examined in the literature, such as the preoper- ative presence or seventy of urodynamic obstruction. Treatment guidelines have emphasized that surgical treatment (or any treat- ment for that matter) should be avoided for men with symptom scores of less than 8 points.

Perhaps the threshold symptom level before prostatectomy is rec- ommended should be even greater, although by how much depends on whether it is worse to operate on a man who will not improve substantially or to deny operative treatment to a man who will indeed improve substantially. The worse the former outcome is than the latter, the greater the symptom threshold should be for recom- mending surgery. An interesting caveat to this analysis is to note that the 11 men with symptom scores of 8 or less had a group mean improvement quality of life score of approximately 2 points, while the 48 with severe symptoms had a group mean improvement of approx- imately 3 points, which is not much greater. While the small sample size argues against overinterpreting this finding, one wonders what the former group of men were responding to when they rated the postoperative quality of life better even with no symptom improve- ment.

Michael J. Barty Medical Practices Evaluation Center Massachusetts General Hospital Boston. Massachusetts